443 related articles for article (PubMed ID: 3818896)
1. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
[TBL] [Abstract][Full Text] [Related]
2. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
3. The prediction and/or detection of ovulation by means of urinary steroid assays.
Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
6. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
7. Puberty, ovarian cycle, pregnancy, and postpartum ovulation in captive Sichuan golden monkeys (Rhinopithecus roxellana) based on changes in urinary and fecal gonadal steroid metabolites.
Muren ; Kusuda S; Doi O; Naito H; Hashikawa H
Theriogenology; 2017 Jan; 87():179-186. PubMed ID: 27743688
[TBL] [Abstract][Full Text] [Related]
8. Enhanced follicle regulatory protein levels accompany reinitiation of ovulatory function after parturition.
Albertson BD; Rodgers KE; Tomai TP; Nolan-Watson K; Zinaman MJ; DiZerega GS
Am J Obstet Gynecol; 1992 Jul; 167(1):158-62. PubMed ID: 1442919
[TBL] [Abstract][Full Text] [Related]
9. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
[TBL] [Abstract][Full Text] [Related]
10. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
Stanczyk FZ; Miyakawa I; Goebelsmann U
Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and determinants of postpartum ovarian function in women in the United States.
Campbell OM; Gray RH
Am J Obstet Gynecol; 1993 Jul; 169(1):55-60. PubMed ID: 8333476
[TBL] [Abstract][Full Text] [Related]
12. Urinary progesterone and pregnanediol. Use for monitoring progesterone treatment.
Stanczyk FZ; Gentzschein E; Ary BA; Kojima T; Ziogas A; Lobo RA
J Reprod Med; 1997 Apr; 42(4):216-22. PubMed ID: 9131494
[TBL] [Abstract][Full Text] [Related]
13. Partial recovery of luteal function after bariatric surgery in obese women.
Rochester D; Jain A; Polotsky AJ; Polotsky H; Gibbs K; Isaac B; Zeitlian G; Hickmon C; Feng S; Santoro N
Fertil Steril; 2009 Oct; 92(4):1410-1415. PubMed ID: 18829008
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG
Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
[TBL] [Abstract][Full Text] [Related]
15. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
16. The return to ovulation following early abortion: a comparison between vacuum aspiration and prostaglandin.
Cameron IT; Baird DT
Acta Endocrinol (Copenh); 1988 Jun; 118(2):161-7. PubMed ID: 3291533
[TBL] [Abstract][Full Text] [Related]
17. The recovery of ovarian function during breast-feeding.
Shaaban MM; Sayed GH; Ghaneimah SA
J Steroid Biochem; 1987; 27(4-6):1043-52. PubMed ID: 3121930
[TBL] [Abstract][Full Text] [Related]
18. High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition.
De Souza MJ; Miller BE; Loucks AB; Luciano AA; Pescatello LS; Campbell CG; Lasley BL
J Clin Endocrinol Metab; 1998 Dec; 83(12):4220-32. PubMed ID: 9851755
[TBL] [Abstract][Full Text] [Related]
19. Exercise induces two types of human luteal dysfunction: confirmation by urinary free progesterone.
Beitins IZ; McArthur JW; Turnbull BA; Skrinar GS; Bullen BA
J Clin Endocrinol Metab; 1991 Jun; 72(6):1350-8. PubMed ID: 1902847
[TBL] [Abstract][Full Text] [Related]
20. Algorithms with Area under the Curve for Daily Urinary Estrone-3-Glucuronide and Pregnanediol-3-Glucuronide to Signal the Transition to the Luteal Phase.
Usala SJ; Alliende ME; Trindade AA
Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056427
[No Abstract] [Full Text] [Related]
[Next] [New Search]
